C07D 295/112
With the ring nitrogen atoms and the doubly bound oxygen or sulfur
Official title: with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
C07D295/112 (With the ring nitrogen atoms and the doubly bound oxygen or sulfur) appears on 322 US grants and 233 published applications in this corpus.
Search patents in C07D- Granted patents
- 322
- Published applications
- 233
- Assignees
- 223
- Inventors
- 1,013
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 7 | 0 |
| 1978 | 5 | 0 |
| 1979 | 6 | 0 |
| 1980 | 7 | 0 |
| 1981 | 6 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 12 | 0 |
| 1985 | 6 | 0 |
| 1986 | 7 | 0 |
| 1987 | 4 | 0 |
| 1988 | 8 | 0 |
| 1989 | 6 | 0 |
| 1990 | 9 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 8 | 0 |
| 2000 | 10 | 0 |
| 2001 | 8 | 1 |
| 2002 | 8 | 14 |
| 2003 | 7 | 12 |
| 2004 | 5 | 14 |
| 2005 | 5 | 12 |
| 2006 | 5 | 15 |
| 2007 | 10 | 11 |
| 2008 | 12 | 15 |
| 2009 | 6 | 9 |
| 2010 | 7 | 11 |
| 2011 | 9 | 8 |
| 2012 | 5 | 8 |
| 2013 | 8 | 6 |
| 2014 | 3 | 10 |
| 2015 | 7 | 10 |
| 2016 | 11 | 12 |
| 2017 | 9 | 10 |
| 2018 | 11 | 9 |
| 2019 | 7 | 5 |
| 2020 | 2 | 7 |
| 2021 | 4 | 6 |
| 2022 | 7 | 8 |
| 2023 | 5 | 2 |
| 2024 | 2 | 7 |
| 2025 | 2 | 7 |
| 2026 | 5 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles4 Aug 2026US 12,697,310 B2Montefiore Medical Center
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Compounds and compositions for nematode treatment10 Mar 2026US 12,568,963 B2Iowa State University Research Foundation, Inc.
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Compounds and compositions for nematode treatment18 Jun 2026US 2026/0165319 A1Iowa State University Research Foundation, Inc.
- Chemical compounds and uses thereof15 Jan 2026US 2026/0015321 A1Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Novel compound and pharmaceutical composition comprising same as active ingredient11 Dec 2025US 2025/0376441 A1Cha University Industry-Academic Cooperation Foundation
Most cited
By later US patents
- Photoactivatable water soluble cross-linking agents containing an onium group198US 5,714,360 ABSI Corporation · 1998
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001
- Nucleic acids encoding microsomal trigyceride transfer protein128US 5,595,872 ABristol-Myers Squibb Company · 1997
- Photoactivatable cross-linking agents containing charged groups for water solubility117US 6,077,698 ASurModics, Inc. · 2000
- 3-Hydroxybutyric acid polymers114US 4,427,614 AImperial Chemical Industries PLC · 1984